There are 248 resources available
Immune checkpoint inhibition for glioblastoma: Update on the first three CheckMate trials
Presenter: Michael Weller
Session: Brain tumours: Updates
Resources:
Slides
Webcast
Peptide based vaccination therapy for glioblastoma
Presenter: Denis Migliorini
Session: Brain tumours: Updates
Resources:
Slides
Immune checkpoint inhibition for patients with brain metastasis: Patient selection and assessment of benefit
Presenter: Emilie Le Rhun
Session: Brain tumours: Updates
Resources:
Slides
State of the art: Neoantigens, T-cell recognition and tumour rejection
Presenter: Yardena Samuels
Session: Tumour antigens and neoantigens
Resources:
Slides
Immunoediting: Anti-tumour immunity and tumour evolution
Presenter: Rachel Rosenthal
Session: Tumour antigens and neoantigens
Resources:
Slides
Translation: Clinical application of neoantigen-reactive T-cells
Presenter: Alena Gros
Session: Tumour antigens and neoantigens
Resources:
Slides
Opportunities to reduce dosing frequency of checkpoint inhibitors
Presenter: Daniel Goldstein
Session: Reducing costs by decreasing either dose or frequency of dosing
Resources:
Slides
Webcast
Dosing reductions of checkpoint inhibitors in lung cancer
Presenter: Berber Piet
Session: Reducing costs by decreasing either dose or frequency of dosing
Resources:
Slides
Webcast
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.